Effects of a Progestin on Frequent and/or Prolonged Bleeding With Nexplanon™
Last updated on July 2021Recruitment
- Recruitment Status
- Recruiting
- Estimated Enrollment
- Same as current
Summary
- Conditions
- Birth Control
- Breakthrough Bleeding
- Contraception
- Implant
- Uterine Bleeding
- Type
- Interventional
- Phase
- Phase 4
- Design
- Allocation: RandomizedIntervention Model: Crossover AssignmentMasking: Triple (Participant, Care Provider, Investigator)Primary Purpose: Treatment
Participation Requirements
- Age
- Between 14 years and 48 years
- Gender
- Only males
Description
The purpose of this study is to find out what effects norethindrone acetate (NTA) has on the duration and recurrence of frequent and/or prolonged bleeding associated with Nexplanon™.
The purpose of this study is to find out what effects norethindrone acetate (NTA) has on the duration and recurrence of frequent and/or prolonged bleeding associated with Nexplanon™.
Tracking Information
- NCT #
- NCT04676061
- Collaborators
- Merck Sharp & Dohme Corp.
- Investigators
- Principal Investigator: Joanna Stacey, MD Baylor Reserach Institute
Get Well Soon